Table 4.
Groups | Number of MII | Number of fertilized (% ± SD) | Number of 2-cell (%± SD) | Number of morula (% ± SD) | Number of hatched (% ± SD) |
---|---|---|---|---|---|
Cont. | 19 | 13 (68.42 ± 0.3) | 8 (61.53 ± 0.6) | 4 (30.76 ± 0.4) | 3 (23.07 ± 0.8) |
Hesp 10 | 27 | 19 (70.37 ± 0.5) | 12 (63.15 ± 0.6) | 6 (31.57 ± 0.7) | 5 (26.31 ± 1.1) |
Hesp 22.5 | 38 | 27 (71.05 ± 0.5)a | 18 (66.66 ± 0.9)a | 9 (33.33 ± 1.2)a | 8 (29.62 ± 1.1)a |
Hesp 50 | 51 | 39 (76.47 ± 0.9)a,b,c | 29 (74.35 ± 1.4)a,b,c | 16 (41.02 ± 0.9)a,b,c | 13 (33.33 ± 1.2)a,b,c |
Note: The control (Cont.) group contained 5% fetal bovine serum (FBS) without hesperidin, Hesp 10 was treated with 10 µmol/L hesperidin, Hesp 22.5 was treated with 22.5 µmol/L hesperidin, and Hesp 50 was treated with 50 µmol/L hesperidin. Values are given as mean ± SD.
ap < 0.05 as compared with the control group.
bp < 0.05 as compared with Hesp10 group.
cp < 0.001 as compared with Hesp 22.5 group.